We are live on ! Find out more
Quantbot Technologies

Quantbot Technologies Portfolio holdings

AUM $2.78B Turnover 51.46%
1-Year Est. Return 9.9%
 

Quantbot Technologies runs computer-driven trading strategies, buying and selling stocks long and short and holding positions from a few seconds to a few days. The firm was founded in 2009 and also trades options, swaps and futures. It is hired to manage money for private funds, whose investors are institutional investors, high net worth individuals and employees. Paul White is its president and chief executive, and Ashar Mahboob is its chief investment officer.

This Fund
S&P 500
This Quarter Est. Return
+6.14%
1 Year Est. Return
+9.9%
3 Year Est. Return
+36.77%
5 Year Est. Return
+5.57%
10 Year Est. Return
+35.66%
AUM
$2.54B
AUM Growth
+$469M
Cap. Flow
+$366M
Cap. Flow %
14.45%
Top 10 Hldgs %
7.35%
Holding
1,922
New
549
Increased
496
Reduced
355
Closed
522
Avg Time Held
0.5 years
Top 10 Avg Time Held
0.1 years
Top 20 Avg Time Held
0.1 years

Top Buys

Rank Stock Value
1
APH icon
Amphenol
APH
+$18M
2
KLAC icon
KLA
KLAC
+$17.2M
3
CVX icon
Chevron
CVX
+$16.1M
4
MRSH icon
Marsh
MRSH
+$15.5M
5
DG icon
Dollar General
DG
+$15.1M

Top Sells

Rank Stock Value
1
ABT icon
Abbott
ABT
+$15.5M
2
WY icon
Weyerhaeuser
WY
+$14.4M
3
MOH icon
Molina Healthcare
MOH
+$14.2M
4
SHW icon
Sherwin-Williams
SHW
+$12M
5
MNST icon
Monster Beverage
MNST
+$10.7M

Sector Composition

Rank Sector Weight
1 Technology 17.32%
2 Financials 17.28%
3 Industrials 14.25%
4 Consumer Discretionary 14.16%
5 Healthcare 10.07%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
ABBV icon
1076
AbbVie
ABBV
$501B
$152K 0.01%
+771
New +$144K
2024 Q3
0 quarters
VTLE icon
1077
DELISTED
Vital Energy
VTLE
$152K 0.01%
5,654
-10,106
-64% -$374K
2023 Q4
3 quarters
REGN icon
1078
Regeneron Pharmaceuticals
REGN
$95.5B
$151K 0.01%
+144
New +$160K
2024 Q3
0 quarters
STR icon
1079
DELISTED
Sitio Royalties
STR
$151K 0.01%
7,252
+6,023
+490% +$136K
2024 Q2
1 quarter
CPRX icon
1080
DELISTED
Catalyst Pharmaceutical
CPRX
$151K 0.01%
+7,601
New +$141K
2024 Q3
0 quarters
BIIB icon
1081
Biogen
BIIB
$36.5B
$151K 0.01%
+778
New +$163K
2024 Q3
0 quarters
AMGN icon
1082
Amgen
AMGN
$237B
$150K 0.01%
+467
New +$153K
2024 Q3
0 quarters
MRNA icon
1083
Moderna
MRNA
$80.7B
$150K 0.01%
+2,241
New +$206K
2024 Q3
0 quarters
HALO icon
1084
Halozyme
HALO
$10.6B
$150K 0.01%
+2,614
New +$150K
2024 Q3
0 quarters
ARWR icon
1085
Arrowhead Research
ARWR
$6.17B
$149K 0.01%
+7,706
New +$188K
2024 Q3
0 quarters
EXEL icon
1086
Exelixis
EXEL
$16.1B
$149K 0.01%
+5,748
New +$143K
2024 Q3
0 quarters
UGP icon
1087
Ultrapar
UGP
$5.56B
$149K 0.01%
38,424
-63,510
-62% -$261K
2023 Q3
4 quarters
CTRN icon
1088
Citi Trends
CTRN
$353M
$148K 0.01%
8,070
+4,250
+111% +$73.4K
2024 Q1
2 quarters
LEGN icon
1089
Legend Biotech
LEGN
$3.12B
$148K 0.01%
+3,032
New +$162K
2024 Q3
0 quarters
MCB icon
1090
Metropolitan Bank Holding
MCB
$1.13B
$147K 0.01%
2,805
-1,060
-27% -$52.4K
2023 Q3
4 quarters
SWTX icon
1091
DELISTED
SpringWorks Therapeutics
SWTX
$147K 0.01%
+4,598
New +$172K
2024 Q3
0 quarters
CLMB icon
1092
Climb Global Solutions
CLMB
$782M
$147K 0.01%
+5,920
New +$118K
2024 Q3
0 quarters
WSR
1093
DELISTED
Whitestone REIT
WSR
$146K 0.01%
10,812
-4,173
-28% -$56K
2024 Q2
1 quarter
AGIO icon
1094
Agios Pharmaceuticals
AGIO
$1.72B
$146K 0.01%
+3,284
New +$149K
2024 Q3
0 quarters
IRON icon
1095
Disc Medicine
IRON
$3.47B
$146K 0.01%
+2,964
New +$139K
2024 Q3
0 quarters
VCEL icon
1096
Vericel
VCEL
$2.97B
$146K 0.01%
+3,445
New +$164K
2024 Q3
0 quarters
PTVE icon
1097
DELISTED
Pactiv Evergreen
PTVE
$145K 0.01%
12,559
+448
+4% +$5.14K
2022 Q1
10 quarters
WS icon
1098
Worthington Steel
WS
$1.93B
$144K 0.01%
4,248
-4,187
-50% -$144K
2024 Q1
2 quarters
HRL icon
1099
Hormel Foods
HRL
$12.7B
$144K 0.01%
+4,529
New +$144K
2024 Q3
0 quarters
LU icon
1100
Lufax Holding
LU
$525M
$143K 0.01%
+4,104
New +$107K
2024 Q3
0 quarters

Similar funds

Quantbot Technologies's Q3 2024 Portfolio in Review

As of Q3 2024, Quantbot Technologies held 1,922 positions worth $2.54B, up 23% from $2.07B the previous quarter. Its ten largest holdings account for 7.4% of the portfolio.

Quantbot Technologies deployed $366M of net new capital in Q3 2024, opening 549 new positions and adding to 496 existing holdings. Its largest new stake was KLA: 219,330 shares worth $17M.

By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 14% a quarter earlier, followed by Financials and Industrials.

On the sell side, the largest reduction was Abbott, an estimated $15.5M trimmed.

  • Quantbot Technologies's largest Q3 2024 buy was KLA: 219,330 shares worth $17M.
  • Quantbot Technologies added most to Amphenol in Q3 2024, an estimated $18M increase.
  • Quantbot Technologies's biggest Q3 2024 reduction was Abbott, cutting an estimated $15.5M.
  • Quantbot Technologies fully exited Wabtec in Q3 2024, selling an estimated $9.8M.
  • Quantbot Technologies's ten largest holdings make up 7.4% of its $2.54B portfolio in Q3 2024.
  • Quantbot Technologies opened 549 new positions and closed 522 in Q3 2024.
  • Quantbot Technologies's portfolio value rose 23% quarter-over-quarter to $2.54B.

Based on Quantbot Technologies's 13F filing for Q3 2024, filed 13 Nov 2024.